{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T02:35:12Z","timestamp":1790303712123,"version":"4.1.0"},"reference-count":8,"publisher":"American Diabetes Association","issue":"3","license":[{"start":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T00:00:00Z","timestamp":1657843200000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,7,1]]},"DOI":"10.2337\/cd21-0118","type":"journal-article","created":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T16:18:06Z","timestamp":1647447486000},"page":"380-384","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":9,"title":["Impact of Insulin-Derived Amyloidosis on Glycemic Control and Insulin Dosing"],"prefix":"10.2337","volume":"40","author":[{"given":"Aaron","family":"Estep","sequence":"first","affiliation":[{"name":"1Department of Family Medicine, Carilion Clinic and Virginia Tech Carilion Family Medicine Residency, Roanoke, VA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7137-4905","authenticated-orcid":false,"given":"Jarrod","family":"Uhrig","sequence":"additional","affiliation":[{"name":"2Department of Endocrinology, Carilion Clinic and Virginia Tech Carilion School of Medicine, Roanoke, VA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis","family":"Bower","sequence":"additional","affiliation":[{"name":"3Department of Surgery, Carilion Clinic and Virginia Tech Carilion School of Medicine, Roanoke, VA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Jarrett","sequence":"additional","affiliation":[{"name":"4Dominion Pathology Associates, Roanoke, VA"},{"name":"5Department of Basic Science Education, Virginia Tech Carilion School of Medicine, Roanoke, VA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","reference":[{"key":"2022071518582356700_B1","doi-asserted-by":"crossref","first-page":"bcr2017219491","DOI":"10.1136\/bcr-2017-219491","article-title":"Isolated insulin-derived amyloidoma of the breast","volume":"2017","author":"Mayhew","year":"2017","journal-title":"BMJ Case Rep"},{"key":"2022071518582356700_B2","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2337\/db18-0846","article-title":"Extreme adhesion activity of amyloid fibrils induces subcutaneous insulin resistance","volume":"68","author":"Nakamura","year":"2019","journal-title":"Diabetes"},{"key":"2022071518582356700_B3","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jdcr.2020.02.011","article-title":"Insulin-derived amyloidosis: the insulin ball, amyloidoma","volume":"6","author":"Samlaska","year":"2020","journal-title":"JAAD Case Rep"},{"key":"2022071518582356700_B4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00256-017-2749-8","article-title":"Imaging characteristics of subcutaneous amyloid deposits in diabetic patients: the \u201cinsulin ball.\u201d","volume":"47","author":"Tanio","year":"2018","journal-title":"Skeletal Radiol"},{"key":"2022071518582356700_B5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/23320885.2016.1247650","article-title":"Progressive insulin-derived amyloidosis in a patient with type 2 diabetes","volume":"3","author":"Shiba","year":"2016","journal-title":"Case Reports Plast Surg Hand Surg"},{"key":"2022071518582356700_B6","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/jdi.13199","article-title":"Insulin-derived amyloidosis without a palpable mass at the insulin injection site: a report of two cases","volume":"11","author":"Nagase","year":"2020","journal-title":"J Diabetes Investig"},{"key":"2022071518582356700_B7","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.amjmed.2013.10.029","article-title":"Insulin-derived amyloidosis and poor glycemic control: a case series","volume":"127","author":"Nagase","year":"2014","journal-title":"Am J Med"},{"key":"2022071518582356700_B8","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4103\/2230-8210.146879","article-title":"Insulin-derived amyloidosis","volume":"19","author":"Gupta","year":"2015","journal-title":"Indian J Endocrinol Metab"}],"container-title":["Clinical Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/clinical\/article-pdf\/40\/3\/380\/685487\/diaclincd210118.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/clinical\/article-pdf\/40\/3\/380\/685487\/diaclincd210118.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T18:58:35Z","timestamp":1657911515000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/clinical\/article\/40\/3\/380\/144835\/Impact-of-Insulin-Derived-Amyloidosis-on-Glycemic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,1]]},"references-count":8,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,7,1]]}},"URL":"https:\/\/doi.org\/10.2337\/cd21-0118","relation":{},"ISSN":["0891-8929","1945-4953"],"issn-type":[{"value":"0891-8929","type":"print"},{"value":"1945-4953","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,1]]}}}